Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance

G. Perseghin, A. Caumo, G. Lattuada, F. De Cobelli, G. Ntali, A. Esposito, E. Belloni, T. Canu, F. Ragogna, P. Scifo, A. Del Maschio, L. Luzi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims Studies have pointed to insulin resistance as a pathogenic factor in fatty liver. Although pancreatic B-cell function is believed to be involved, its role is unclear. This study was undertaken to test whether fasting C-peptide, an index of fasting B-cell function, was related to intra-hepatic fat (IHF) content in non-diabetic humans. Methods We assessed, retrospectively, fasting plasma C-peptide concentration in 31 patients with fatty liver and 62 individuals without fatty liver. The IHF content was measured by proton magnetic resonance spectroscopy ( 1H-MRS), while insulin sensitivity was estimated based on fasting plasma glucose and insulin with the homestasis model assessment (HOMA) 2 method. Results Age, sex and body mass index (BMI) were not different between groups. Patients with fatty liver had higher fasting insulin (P <0.01), C-peptide (P <0.005) and lower insulin sensitivity (HOMA2-%S). Fasting insulin alone explained 14% of the IHF content variability (P <0.001); inclusion of fasting C-peptide in multivariate regression explained up to 32% (P <0.001). A subgroup analysis was performed by matching 1 : 1 for HOMA2-%S. These data were analysed by conditional logistic regression which showed that, when HOMA2-%S was matched between groups, fasting C-peptide remained the only significant predictor of fatty liver. Conclusions Non-diabetic individuals with fatty liver are characterized by increased fasting plasma C-peptide concentration, irrespective of their insulin resistant state.

Original languageEnglish
Pages (from-to)847-854
Number of pages8
JournalDiabetic Medicine
Volume26
Issue number9
DOIs
Publication statusPublished - Sep 2009

Fingerprint

C-Peptide
Fatty Liver
Insulin Resistance
Fasting
Insulin
Fats
Liver
Insulin-Secreting Cells
Body Mass Index
B-Lymphocytes
Research Design
Logistic Models
Glucose

Keywords

  • Free fatty acids
  • Homeostasis model assessment
  • Intra-hepatic fat
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance. / Perseghin, G.; Caumo, A.; Lattuada, G.; De Cobelli, F.; Ntali, G.; Esposito, A.; Belloni, E.; Canu, T.; Ragogna, F.; Scifo, P.; Del Maschio, A.; Luzi, L.

In: Diabetic Medicine, Vol. 26, No. 9, 09.2009, p. 847-854.

Research output: Contribution to journalArticle

@article{17b1866bbc3f4af9af679f422d1b736c,
title = "Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance",
abstract = "Aims Studies have pointed to insulin resistance as a pathogenic factor in fatty liver. Although pancreatic B-cell function is believed to be involved, its role is unclear. This study was undertaken to test whether fasting C-peptide, an index of fasting B-cell function, was related to intra-hepatic fat (IHF) content in non-diabetic humans. Methods We assessed, retrospectively, fasting plasma C-peptide concentration in 31 patients with fatty liver and 62 individuals without fatty liver. The IHF content was measured by proton magnetic resonance spectroscopy ( 1H-MRS), while insulin sensitivity was estimated based on fasting plasma glucose and insulin with the homestasis model assessment (HOMA) 2 method. Results Age, sex and body mass index (BMI) were not different between groups. Patients with fatty liver had higher fasting insulin (P <0.01), C-peptide (P <0.005) and lower insulin sensitivity (HOMA2-{\%}S). Fasting insulin alone explained 14{\%} of the IHF content variability (P <0.001); inclusion of fasting C-peptide in multivariate regression explained up to 32{\%} (P <0.001). A subgroup analysis was performed by matching 1 : 1 for HOMA2-{\%}S. These data were analysed by conditional logistic regression which showed that, when HOMA2-{\%}S was matched between groups, fasting C-peptide remained the only significant predictor of fatty liver. Conclusions Non-diabetic individuals with fatty liver are characterized by increased fasting plasma C-peptide concentration, irrespective of their insulin resistant state.",
keywords = "Free fatty acids, Homeostasis model assessment, Intra-hepatic fat, Magnetic resonance spectroscopy",
author = "G. Perseghin and A. Caumo and G. Lattuada and {De Cobelli}, F. and G. Ntali and A. Esposito and E. Belloni and T. Canu and F. Ragogna and P. Scifo and {Del Maschio}, A. and L. Luzi",
year = "2009",
month = "9",
doi = "10.1111/j.1464-5491.2009.02785.x",
language = "English",
volume = "26",
pages = "847--854",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance

AU - Perseghin, G.

AU - Caumo, A.

AU - Lattuada, G.

AU - De Cobelli, F.

AU - Ntali, G.

AU - Esposito, A.

AU - Belloni, E.

AU - Canu, T.

AU - Ragogna, F.

AU - Scifo, P.

AU - Del Maschio, A.

AU - Luzi, L.

PY - 2009/9

Y1 - 2009/9

N2 - Aims Studies have pointed to insulin resistance as a pathogenic factor in fatty liver. Although pancreatic B-cell function is believed to be involved, its role is unclear. This study was undertaken to test whether fasting C-peptide, an index of fasting B-cell function, was related to intra-hepatic fat (IHF) content in non-diabetic humans. Methods We assessed, retrospectively, fasting plasma C-peptide concentration in 31 patients with fatty liver and 62 individuals without fatty liver. The IHF content was measured by proton magnetic resonance spectroscopy ( 1H-MRS), while insulin sensitivity was estimated based on fasting plasma glucose and insulin with the homestasis model assessment (HOMA) 2 method. Results Age, sex and body mass index (BMI) were not different between groups. Patients with fatty liver had higher fasting insulin (P <0.01), C-peptide (P <0.005) and lower insulin sensitivity (HOMA2-%S). Fasting insulin alone explained 14% of the IHF content variability (P <0.001); inclusion of fasting C-peptide in multivariate regression explained up to 32% (P <0.001). A subgroup analysis was performed by matching 1 : 1 for HOMA2-%S. These data were analysed by conditional logistic regression which showed that, when HOMA2-%S was matched between groups, fasting C-peptide remained the only significant predictor of fatty liver. Conclusions Non-diabetic individuals with fatty liver are characterized by increased fasting plasma C-peptide concentration, irrespective of their insulin resistant state.

AB - Aims Studies have pointed to insulin resistance as a pathogenic factor in fatty liver. Although pancreatic B-cell function is believed to be involved, its role is unclear. This study was undertaken to test whether fasting C-peptide, an index of fasting B-cell function, was related to intra-hepatic fat (IHF) content in non-diabetic humans. Methods We assessed, retrospectively, fasting plasma C-peptide concentration in 31 patients with fatty liver and 62 individuals without fatty liver. The IHF content was measured by proton magnetic resonance spectroscopy ( 1H-MRS), while insulin sensitivity was estimated based on fasting plasma glucose and insulin with the homestasis model assessment (HOMA) 2 method. Results Age, sex and body mass index (BMI) were not different between groups. Patients with fatty liver had higher fasting insulin (P <0.01), C-peptide (P <0.005) and lower insulin sensitivity (HOMA2-%S). Fasting insulin alone explained 14% of the IHF content variability (P <0.001); inclusion of fasting C-peptide in multivariate regression explained up to 32% (P <0.001). A subgroup analysis was performed by matching 1 : 1 for HOMA2-%S. These data were analysed by conditional logistic regression which showed that, when HOMA2-%S was matched between groups, fasting C-peptide remained the only significant predictor of fatty liver. Conclusions Non-diabetic individuals with fatty liver are characterized by increased fasting plasma C-peptide concentration, irrespective of their insulin resistant state.

KW - Free fatty acids

KW - Homeostasis model assessment

KW - Intra-hepatic fat

KW - Magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=69249170017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249170017&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2009.02785.x

DO - 10.1111/j.1464-5491.2009.02785.x

M3 - Article

C2 - 19719704

AN - SCOPUS:69249170017

VL - 26

SP - 847

EP - 854

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 9

ER -